Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Cost, however, could limit access
Conclusions/interpretation At current prices, use of SGLT2is, but not GLP-1 RAs, would be cost-effective when considering only their cardiovascular and kidney disease benefits for people with type 2 diabetes
Ready for immediate dispatch
Compounded products are not approved or verified by the FDA for safety, effectiveness, or quality
Dowdle WE, Nyfeler B, Nagel J, Elling RA, Liu S, Triantafellow E, et al
Compounded GLP-1 drugs became widely available during shortages of semaglutide and tirzepatide, helping some patients maintain access to treatment
US$ 20.39
US$ 26.34
US$ 29.12
US$ 26.35
US$ 22.17
US$ 24.92
US$ 29.89
US$ 26.16
US$ 29.29
US$ 20.47
US$ 28.08
